Eli Lilly (LLY) Exchange Rate Effect (2009 - 2026)

Eli Lilly has reported Exchange Rate Effect for 18 years, with the latest figure at $67.0 million in Q1 2026.

• For the quarter ending Q1 2026, Exchange Rate Effect fell 49.24% year-over-year to $67.0 million; the trailing twelve-month figure through Mar 2026 stood at $307.0 million (up 337.07% YoY), and the FY2025 full-year result was $372.0 million, up 225.25% from the prior year.
• Exchange Rate Effect for Q1 2026 stood at $67.0 million, up from -$67.1 million in the prior quarter.
• The five-year high for Exchange Rate Effect was $275.4 million in Q2 2025, with the low at -$428.8 million in Q4 2024.
• Historically, Exchange Rate Effect has averaged $8.4 million across 5 years, with a median of $9.2 million in 2023.
• Annual changes were most pronounced in 2022 — Exchange Rate Effect slumped 906.98% — and 2024, when it surged 4181.13%.
• Eli Lilly's Exchange Rate Effect stood at -$128.2 million in 2022, then surged by 201.17% to $129.7 million in 2023, then tumbled by 430.61% to -$428.8 million in 2024, then jumped by 84.35% to -$67.1 million in 2025, then surged by 199.85% to $67.0 million in 2026.
• The last three Exchange Rate Effect figures came in at $67.0 million (Q1 2026), -$67.1 million (Q4 2025), and $31.7 million (Q3 2025), per Business Quant data.